Mutational Screening in KRAS, BRAF, EGFR, C-KIT and PDGFRain Colorectal Carcinoma (CRC) and Non-Small Cell Lung Cancer (NSCLC) Using Next-Generation Sequencing (NGS)

被引:0
|
作者
Hinrichsen, T.
Wachter, O.
Dockhorn-Dworniczak, B.
Klein, H-G
机构
[1] Ctr Human Genet & Lab Med Dr Klein & Dr Rost, Munich, Bavaria, Germany
[2] Dept Pathol, Kempten, Bavaria, Germany
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
2140
引用
收藏
页码:513A / 513A
页数:1
相关论文
共 50 条
  • [41] Routine Clinical Mutation Profiling of Non-Small Cell Lung Cancer Using Next-Generation Sequencing
    Deeb, Kristin K.
    Hohman, Colleen M.
    Risch, Nicholas F.
    Metzger, Daniel J.
    Starostik, Petr
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (07) : 913 - 921
  • [42] Validation and implementation of next-generation sequencing in liquid biopsies by a novel NGS platform: Focus on non-small cell lung cancer
    Bisgin, Atil
    Sonmezler, Ozge
    Boga, Ibrahim
    CANCER RESEARCH, 2018, 78 (13)
  • [43] Optimal next-generation sequencing (NGS) panel for estimating tumor mutation burden (TMB) and its clinical implication for non-small cell lung cancer (NSCLC).
    Ikeda, Takaya
    Oi, Hajime
    Yoh, Kiyotaka
    Matsumoto, Shingo
    Kato, Terufumi
    Nishino, Kazumi
    Nakamura, Atsushi
    Nakachi, Ichiro
    Sakakibara-Konishi, Jun
    Daga, Haruko
    Furuya, Naoki
    Taima, Kageaki
    Iwama, Eiji
    Ebi, Noriyuki
    Shibata, Yuji
    Izumi, Hiroki
    Nosaki, Kaname
    Zenke, Yoshitaka
    Goto, Koichi
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [44] Gene rearrangement detection by next-generation sequencing in patients with non-small cell lung carcinoma
    Brisudova, Aneta
    Skarda, Jozef
    BIOMEDICAL PAPERS-OLOMOUC, 2020, 164 (02): : 127 - 132
  • [45] KRAS mutations (MTs) in non-small cell lung cancer (NSCLC) versus colorectal cancer (CRC): Implications for cetuximab therapy
    Danenberg, K. D.
    Grimminger, P. P.
    Mack, P. C.
    Danenberg, P. V.
    Cooc, J.
    Stephens, C.
    Reddy, S. K.
    Li, T.
    Gandara, D. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [46] Building an effective concordance study: Plasma Next Generation Sequencing (NGS) for oncogenic fusion detection in non-small cell lung carcinoma (NSCLC)
    Supplee, Julianna G.
    Milan, Marina S.
    Potts, Kristy T.
    Sholl, Lynette M.
    Shaffer, Tristan S.
    Lim, Lee P.
    Janne, Pasi A.
    Oxnard, Geoffrey R.
    Paweletz, Cloud P.
    CANCER RESEARCH, 2019, 79 (13)
  • [47] Mutational profile by targeted next generation sequencing of non-small cell lung cancer in the Mexican population
    Hernandez-Pedro, Norma
    Soca-Chafre, Giovanny
    Alaez-Verson, Carmen
    Carrillo-Sanchez, Karol
    Aviles-Salas, Alejandro
    Vergara, Edgar
    Arrieta, Oscar
    SALUD PUBLICA DE MEXICO, 2019, 61 (03): : 308 - 317
  • [48] Prospective mutational characterization of Japanese patients with non-small cell lung cancer using surgically resected tumor specimens by next-generation sequencing
    Koh, Y.
    Kenmotsu, H.
    Serizawa, M.
    Isaka, M.
    Mori, K.
    Takahashi, T.
    Endo, M.
    Nakajima, T.
    Ohde, Y.
    Yamamoto, N.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S12 - S12
  • [49] A cell-free RNA-based next-generation sequencing (NGS) assay for the detection of actionable gene fusions in patients with non-small cell lung cancer (NSCLC)
    Choudhury, Yukti
    Cher, Chae Yin
    Ho, Jia Min
    Chan, Claire
    Teh, Mun Wei
    Ngeow, Kao Chin
    Pek, Michelle
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [50] Identification of rare gene fusions in non-small cell lung cancer with next-generation sequencing
    Zhuo, M.
    Gu, W.
    Chen, R.
    Yuan, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S992 - S992